Midodrine for sepsis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 20 Mar 2024: Trial registered, NCT06319248
  2. 14 May 2024: Trial started, NCT06319248

The trials

NCT06319248: MID-STEP (MIDodrine for Sepsis Treatment and Early vasoPressor Weaning) Trial

State
Under way
Phase
Phase 2
People
308 planned
Started
14 May 2024
Primary completion
30 May 2029
Arms
Standard of Care with Midodrine Group
Results
None posted
  1. 20 Mar 2024: Trial registered
  2. 14 May 2024: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.